210 related articles for article (PubMed ID: 35991145)
21. Prognosis of Patients With Triple-negative Breast Cancer: A Population-based Study From SEER Database.
Zhou HL; Chen DD
Clin Breast Cancer; 2023 Apr; 23(3):e85-e94. PubMed ID: 36669957
[TBL] [Abstract][Full Text] [Related]
22. Nomograms for Predicting Risk and Survival of Esophageal Cancer Lung Metastases: a SEER Analysis.
He W; Yu Y; Yan Z; Luo N; Yang W; Li F; Jin H; Zhang Y; Ma X; Ma M
J Cancer; 2024; 15(11):3370-3380. PubMed ID: 38817873
[No Abstract] [Full Text] [Related]
23. Establishment and verification of a nomogram to predict tumor-specific mortality risk in triple-negative breast cancer: a competing risk model based on the SEER cohort study.
Li Z; Shi Y; Wu L; Zhang H; Xue J; Li W; Wang X; Zhang L; Wang Q; Duo L; Wang M; Wang G
Gland Surg; 2022 Dec; 11(12):1961-1975. PubMed ID: 36654948
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors and individualized nomograms predicting overall survival in stage IV rectal cancer patients with different metastatic status: a SEER-based study.
Ge H; Zhou Z; Li Y; Wang D; Güngör C
Transl Cancer Res; 2022 Sep; 11(9):3141-3155. PubMed ID: 36237239
[TBL] [Abstract][Full Text] [Related]
25. The incidence, risk factors and predictive nomograms for early death of lung cancer with synchronous brain metastasis: a retrospective study in the SEER database.
Shen H; Deng G; Chen Q; Qian J
BMC Cancer; 2021 Jul; 21(1):825. PubMed ID: 34271858
[TBL] [Abstract][Full Text] [Related]
26. Risk factors, survival analysis, and nomograms for distant metastasis in patients with primary pulmonary large cell neuroendocrine carcinoma: A population-based study.
Song Z; Zou L
Front Endocrinol (Lausanne); 2022; 13():973091. PubMed ID: 36329892
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Nomogram for Overall Survival in Small Cell Lung Cancer Patients Treated with Chemotherapy: A SEER-Based Retrospective Cohort Study.
Liang M; Chen M; Singh S; Singh S
Adv Ther; 2022 Jan; 39(1):346-359. PubMed ID: 34729705
[TBL] [Abstract][Full Text] [Related]
28. Nomogram for predicting overall survival in patients with triple-negative apocrine breast cancer: Surveillance, epidemiology, and end results-based analysis.
Xu Y; Zhang W; He J; Wang Y; Chen R; Shi W; Wan X; Shi X; Huang X; Wang J; Zha X
Breast; 2022 Dec; 66():8-14. PubMed ID: 36084385
[TBL] [Abstract][Full Text] [Related]
29. Establishment of the diagnostic and prognostic nomograms for pancreatic cancer with bone metastasis.
Liu Z; Liu H; Wang D
Sci Rep; 2022 Oct; 12(1):18085. PubMed ID: 36302941
[TBL] [Abstract][Full Text] [Related]
30. Risk and prognostic nomograms for colorectal neuroendocrine neoplasm with liver metastasis: a population-based study.
Ding X; Tian S; Hu J; Wang G; Yu X; Fu D; Yuan Y; Wang L; Wang Z
Int J Colorectal Dis; 2021 Sep; 36(9):1915-1927. PubMed ID: 34061225
[TBL] [Abstract][Full Text] [Related]
31. Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.
Feng Y; Wang Y; Xie Y; Wu S; Li Y; Li M
BMC Cancer; 2021 Apr; 21(1):450. PubMed ID: 33892663
[TBL] [Abstract][Full Text] [Related]
32. Risk factors, prognostic predictors, and nomograms for pancreatic cancer patients with initially diagnosed synchronous liver metastasis.
Cao BY; Tong F; Zhang LT; Kang YX; Wu CC; Wang QQ; Yang W; Wang J
World J Gastrointest Oncol; 2023 Jan; 15(1):128-142. PubMed ID: 36684042
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors in extensive-stage small cell lung cancer patients with organ-specific metastasis: unveiling commonalities and disparities.
Wu Y; Zhang J; Zhou W; Yuan Z; Wang H
J Cancer Res Clin Oncol; 2024 Feb; 150(2):74. PubMed ID: 38305793
[TBL] [Abstract][Full Text] [Related]
34. Nomogram for predicting survival in triple-negative breast cancer patients with histology of infiltrating duct carcinoma: a population-based study.
Dai D; Jin H; Wang X
Am J Cancer Res; 2018; 8(8):1576-1585. PubMed ID: 30210925
[TBL] [Abstract][Full Text] [Related]
35. Construction and Validation of Nomograms Predicting Survival in Triple-Negative Breast Cancer Patients of Childbearing Age.
Cui X; Song D; Li X
Front Oncol; 2020; 10():636549. PubMed ID: 33628740
[TBL] [Abstract][Full Text] [Related]
36. Predictive nomograms for risk and prognostic factors in metastatic bladder cancer: a population-based study.
Shi S; Peng G; Luo L; Li D
Transl Cancer Res; 2023 Dec; 12(12):3284-3302. PubMed ID: 38192983
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of nomograms for predicting survival in patients with de novo metastatic triple-negative breast cancer.
Chen MS; Liu PC; Yi JZ; Xu L; He T; Wu H; Yang JQ; Lv Q
Sci Rep; 2022 Aug; 12(1):14659. PubMed ID: 36038627
[TBL] [Abstract][Full Text] [Related]
38. Risk Factors, Prognostic Factors, and Nomograms for Bone Metastasis in Patients with Newly Diagnosed Clear Cell Renal Cell Carcinoma: A Large Population-Based Study.
Zhou H; Yang S; Xie T; Wang L; Zhong S; Sheng T; Fan G; Liao X; Xu Y
Front Surg; 2022; 9():877653. PubMed ID: 35433803
[TBL] [Abstract][Full Text] [Related]
39. Risk Factors, Prognostic Factors, and Nomograms for Distant Metastasis in Patients With Newly Diagnosed Osteosarcoma: A Population-Based Study.
Chen B; Zeng Y; Liu B; Lu G; Xiang Z; Chen J; Yu Y; Zuo Z; Lin Y; Ma J
Front Endocrinol (Lausanne); 2021; 12():672024. PubMed ID: 34393996
[TBL] [Abstract][Full Text] [Related]
40. Nomogram for predicting preoperative regional lymph nodes metastasis in patients with metaplastic breast cancer: a SEER population-based study.
Zhang M; Wang B; Liu N; Wang H; Zhang J; Wu L; Zhao A; Wang L; Zhao X; Yang J
BMC Cancer; 2021 May; 21(1):565. PubMed ID: 34001061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
